| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4510 | Rtoxa-43 | Novel Potent Dual Orexin Receptor Agonist |
|
| DCC4511 | Ru-0207148 | Novel allosteric inhibitor of soluble adenylyl cyclase (sAC) |
|
| DCC4512 | Ru-24969 Hemisuccinate | Potent serotonin SR-1A/SR-1B and moderate SR-2C agonist |
|
| DCC4513 | ru5135 | Potent vertebrate GABAa antagonist |
|
| DCC4514 | Ru-56187 | Novel non-steroidal antiandrogen, downregulating c-myc messenger RNAs |
|
| DCC4515 | Ru59063 | Potent non-steroidal antiandrogen |
|
| DCC4516 | Ru-79115 | Novel DNA gyrase B inhibitor |
|
| DCC4517 | Ru85053 | Novel inhibitor of Src protein tyrosine kinase SH2 |
|
| DCC4518 | Ruboxastaurin Mesilate Hydrate | PKCβ-selective inhibitor |
|
| DCC4519 | rugulactone | The first small molecule inhibitor of ThiD; IkB kinase (IKK) inhibitor; antibiotic |
|
| DCC4520 | Ru-nt-102 | Novel Ricin Inhibitor, Targeting Ribosome Binding |
|
| DCC4521 | Ru-nt-70 | Novel Ricin Inhibitor, Targeting Ribosome Binding |
|
| DCC4522 | Ru-nt-75 | Novel Ricin Inhibitor, Targeting Ribosome Binding |
|
| DCC4523 | Ru-nt-93 | Novel Ricin Inhibitor, Targeting Ribosome Binding |
|
| DCC4524 | rutaecarpine-17 | Inhibitor of Adipogenesis/Lipogenesis with AMPK Activation and UPR Suppression, Reducing Lipid Accumulation in Adipocytes |
|
| DCC4525 | Ruvbl1/2-in-b | Novel specific RUVBL1/2 ATPase inhibitor, radiosensitizing NSCLC, but not normal lung epithelial cells |
|
| DCC4526 | Rvd2n-3 Dpa | Natural potent macrophage uptake enhancer of S. aureus and zymosan A bioparticles |
|
| DCC4527 | Rwj50271 | Inhibitor of LFA-1/ICAM-1 Mediated Cell Adhesion |
|
| DCC4528 | Rwj-51204 | Potent and selective of the benzodiazepine site on GABA(A) receptors |
|
| DCC4529 | rwj-58259 | Selective antagonist of protease activated receptor-1 |
|
| DCC4530 | Rwj-60475 | Novel CD45 phosphatase inhibitor |
|
| DCC4531 | Rx-111 | Novel small molecule inhibitor of protein interaction with glycosaminoglycans (SMIGs), exercising broad spectrum anti-inflammatory activity by inhibition of protein binding to the cell surface GAG, heparan sulfate |
|
| DCC4532 | Rxfp3/4-agonist-1 | The first Small Molecule RXFP3/4 Agonist, Increasing Food Intake in Rats Upon Acute Central Administration |
|
| DCC4533 | Ryl-634 | Novel potent broad-spectrum antiviral inhibitor, showing excellent broad-spectrum inhibition activity against various pathogenic viruses, including hepatitis c virus (HCV), dengue virus (DENV), zika virus (ZIKV), Chikungunya virus (CHIKV), enterovirus 71 |
|
| DCC4534 | S(-)-8-hydroxy-dpat Hydrobromide [78095-20-2] | Partial 5-HT1A serotonin receptor agonist |
|
| DCC4535 | S(+)-o-desmethylraclopride Hbr | Selective D2 dopamine receptor antagonist; Precursor to radiolabeled S-(-)-raclopride |
|
| DCC4536 | S007-1558 | The most viable GPVI modulator, acting as a potent antithrombotic agent |
|
| DCC4537 | S05014 | Novel highly effective tyrosinase inhibitor with great potential to be utilized in anti-Parkinsonian syndrome |
|
| DCC4538 | S06-1011 | Highly Potent and Selective Butyrylcholinesterase (BChE) Inhibitor for Cognitive Improvement and Neuroprotection |
|
| DCC4539 | S06-1031 | Highly Potent and Selective Butyrylcholinesterase (BChE) Inhibitor for Cognitive Improvement and Neuroprotection |
|
